Release test results
99.722%HPLC purity · meets ≥ 99.5% spec
Mass-spec identityConfirmed · 10.04 mg
Related impurities (total)0.278%
Endotoxin<1.0 EU/mg
HPLC retention time4.87 min
MethodHPLC + LC-MS
ResultPass · meets spec
Lot record
CompoundWolverine
Presentation10 MG
Lot numberRGX-26-WOLVERINE-1039
COA numberNS-2026-05040
Test date02 Sep 2026
Release date05 Sep 2026
Independent labNordicstar Labs
StatusCurrent
Wolverine — lot history
| Lot | Presentation | Tested | HPLC purity | Status |
|---|---|---|---|---|
| RGX-26-WOLVERINE-660 | 20 MG | Sep 7, 2026 | 99.568% | Superseded |
| RGX-26-WOLVERINE-760 | 20 MG | Sep 5, 2026 | 99.751% | Superseded |
| RGX-26-WOLVERINE-1040 | 20 MG | Sep 4, 2026 | 99.760% | Current |
| RGX-26-WOLVERINE-761 | 10 MG | Sep 3, 2026 | 99.758% | Superseded |
| RGX-26-WOLVERINE-661 | 10 MG | Sep 3, 2026 | 99.713% | Superseded |
| RGX-26-WOLVERINE-1039 this lot | 10 MG | Sep 2, 2026 | 99.722% | Current |
!
Research use only
This lot record documents a research compound sold for laboratory use only — not for human or animal consumption. Results are as tested by Nordicstar Labs; retained samples are archived for five years. Research Use Agreement →